Answer
The enfortumab vedotin antibody–drug conjugate exhibits a multi-exponential elimination decline with a half-life of 3.6 days.
Sources for this answer
- Padcev 20 mg and 30 mg powder for concentrate for solution for infusionAstellas Pharma Ltd · emc · SmPC §5.2 Pharmacokinetic properties · Version 11Document updated
Sources checked